TrialScope Adds Top European Pharmaceutical Company to Growing Customer Base
JERSEY CITY, N.J., November 18 2015
TrialScope, the global leader in clinical trial transparency and compliance solutions, today announced that a European multi-national pharmaceutical company selected the PharmaCM clinical trial disclosure platform to support their transparency efforts. Through a competitive evaluation process, the sponsor selected PharmaCM and the EudraCT Results Reporting Module to maintain compliance with US and European clinical trial registration and results reporting requirements. The new customer adds to the global footprint of TrialScope’s existing customer base which includes the US, Japan and Europe.
The PharmaCM platform enables sponsors to efficiently manage clinical trial transparency efforts and ultimately, improve their compliance performance. The EudraCT Module supports reuse of disclosure content, minimizing the efforts required to align disclosure content across different regional registries.
Mike Forgash, CEO, TrialScope, commented, “As clinical trial disclosure regulations and requirements continue to evolve, it is becoming increasingly important for sponsors to improve their disclosure performance and their overall clinical trial transparency programs. TrialScope’s PharmaCM platform supports these objectives with robust content management, configurable alerts and notifications, and continuing regulatory monitoring of changing compliance obligations. This allows companies of all sizes to improve compliance efforts and ultimately, their compliance performance.”
Brian Flaherty, Vice President, Business Development noted, ”We are seeing a heightened awareness and increased prioritization of clinical trial disclosure capabilities across the industry. As the complexities of global transparency continue to expand, companies are looking for ways to leverage technologies like PharmaCM to reuse disclosure content and optimize global registration and reporting processes. We are seeing a much greater emphasis on compliance performance.”
TrialScope simplifies the complexities of clinical transparency management. TrialScope is a proven solution that has been implemented successfully and rigorously tested in the most complex environments with solutions that are currently implemented at 13 of the top 30 global clinical trial sponsors, including 6 of the top 10. The company’s market-driven solution and expertise enable sponsors to improve their clinical trial process, mitigate registry and lifecycle risk, and ultimately achieve greater compliance. TrialScope technology is offered via a validation-ready SaaS platform hosted in a private cloud.